Aripiprazole

Product manufactured by Remedyrepack Inc.

Application Nr Approved Date Route Status External Links
ANDA202101 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Aripiprazole Is Indicated For The Treatment Of: •schizophrenia [see Clinical Studies (14.1)] Additional Pediatric Use Information Is Approved For Otsuka America Pharmaceutical, Inc.’s Abilify® (aripiprazole) Product. However, Due To Otsuka America Pharmaceutical, Inc.’s Marketing Exclusivity Rights, This Drug Product Is Not Labeled With That Information. Aripiprazole Is An Atypical Antipsychotic Indicated As Oral Formulations For The: •schizophrenia (14.1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Aripiprazole ARIPIPRAZOLE ZINC1851149

Comments